Clinical Trials Directory

Trials / Completed

CompletedNCT03162016

Treatment Off Gingival Recession Defects Using a Xenogenic Acellular Dermal Matrix Compared to Connective Tissue Graft.

Treatment of Multiple Gingival Recession Defects Using a Xenogenic Acellular Dermal Matrix Compared to Connective Tissue Graft: a Randomized Controlled Clinical Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Centre Hospitalier Universitaire de Nice · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers
Not accepted

Summary

Limitation of donor site and significant postoperative morbidity are often described in connective tissue graft harvesting. We want to show if mucoderm used in tunnel technique to recover miller class I and II recessions defects could be an alternative to connective tissue graft.

Detailed description

Connective tissue graft harvested from the palate does not always have sufficient size to cover multiple recession defects. Moreover, connective tissue graft shows significant postoperative morbidity to treat generalized multiple gingival recessions. The goal of this study is to show if Mucoderm could be considered has a substitute of connective tissue graft in the coverage of gingival recession defects.

Conditions

Interventions

TypeNameDescription
PROCEDUREtransplantsTransplant of palatine tissue and transplant of connective tissue Mucoderm

Timeline

Start date
2017-06-23
Primary completion
2020-09-07
Completion
2020-09-07
First posted
2017-05-22
Last updated
2026-03-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03162016. Inclusion in this directory is not an endorsement.